K770458

Substantially Equivalent

BILIRUBIN PROCEDURE, TEKPOINT TOT & DIR.

Applicant: Icn Pharmaceuticals, Inc.
Product code: CIG
Advisory panel: Clinical Chemistry
Date received: 1977-03-08
Decision date: 1977-05-10
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Orangeburg, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.